Impact of the Norepinephrine Prodrug Droxidopa on the QTc Interval in Healthy Individuals

A double‐blind, 4‐period crossover study (NCT01327066) was conducted to assess the effect of the novel norepinephrine prodrug droxidopa on the QT interval in in healthy subjects. Subjects were randomized to receive a single dose of droxidopa 600 mg (maximal dose) and 2000 mg (supratherapeutic dose)...

Descripción completa

Detalles Bibliográficos
Autores principales: White, William B., Hewitt, L. Arthur, Mehdirad, Ali A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901008/
https://www.ncbi.nlm.nih.gov/pubmed/29024579
http://dx.doi.org/10.1002/cpdd.393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901008/
https://www.ncbi.nlm.nih.gov/pubmed/29024579
http://dx.doi.org/10.1002/cpdd.393

Ejemplares similares